Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors

被引：1

作者：

Meguro, Masaki ^{[1
]}

Miyauchi, Satoru ^{[2
]}

Kanao-Arisumi, Yukiko ^{[3
]}

Naito, Satoru ^{[4
]}

Suzuki, Kanae ^{[1
]}

Inoue, Shinichi ^{[5
]}

Yamada, Keisuke ^{[6
]}

Homma, Tsuyoshi ^{[1
]}

Chiba, Kiyoshi ^{[1
]}

Nara, Futoshi ^{[7
]}

Furuzono, Shinji ^{[1
]}

机构：

[1] Daiichi Sankyo Co Ltd, Shinagawa R&D Ctr, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Technol Div, Technol Business Management Grp, 1-12-1 Shinomiya, Hiratsuka, Kanagawa 2540014, Japan

[3] Pharmaun Co Ltd, 1-23-39 Hiikawa,Jounan Ku, Fukuoka, Fukuoka 8140153, Japan

[4] Daiichi Sankyo Business Associe Co Ltd, Site Operat Dept, Shinagawa Site Operat Grp, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[5] Daiichi Sankyo Inc, 211 Mt Airy Rd, Basking Ridge, NJ 07920 USA

[6] Daiichi Sankyo Co Ltd, Med Affairs Div, Med Affairs Planning Dept, 3-5-1 Nihonbashi Honcho,Chuo Ku, Tokyo 1038426, Japan

[7] Shin Nippon Biomed Labs Ltd, 8-1-28 Akashicho,Chuo Ku, Tokyo 1040044, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2024年 / 108卷

关键词：

Aldosterone; Aldosterone synthase inhibitor; Sulfone; Amino-pyrimidine; IN-VIVO ACTIVITY; POTENTIAL TREATMENTS; DISCOVERY; LCI699; THIOLS;

D O I：

10.1016/j.bmc.2024.117775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

4-[(5-[2-Methyl-5-(methylsulfonyl)pentan-2-yl]sulfonylpyrimidin-4-yl)amino]benzonitrile 2 was identified as a novel potent aldosterone synthase inhibitor. Compound 2 was found to inhibit human CYP11B2 in the nanomolar range, and showed an aldosterone-lowering effect in a furosemide-treated cynomolgus monkey model. Although human CYP11B2 has the high homology sequence with human CYP11B1, compound 2 showed more than 80 times higher selectivity over human CYP11B1 in vitro.

引用

页数：15

共 50 条

[1] Synthesis of annulated pyridines as inhibitors of aldosterone synthase (CYP11B2)
Martin, Rainer E.
Lehmann, Johannes
Alzieu, Thibaut
Lenz, Mario
Corrales, Marjorie A. Carnero
Aebi, Johannes D.
Marki, Hans Peter
Kuhn, Bernd
Amrein, Kurt
Mayweg, Alexander V.
Britton, Robert
ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (25) : 5922 - 5927
[2] Discovery of orally available aldosterone synthase (CYP11B2) inhibitors
Papillon, Julien P. N.
Adams, Christopher M.
Hu, Qi-Ying
Ksander, Gary M.
Carvalho, Jose
Lou, Changgang
Singh, Alok K.
Zhang, Chun
Gangl, Eric
Maniara, Wieslawa M.
Amaral, Adam
Logman, Michael
Smith, Sherri
Jeng, Arco Y.
Rigel, Dean F.
Beil, Michael E.
Fu, Fumin
Hu, Chii-Whei
LaSala, Daniel
Rajan, Srinivasan
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
[3] Development of Highly Selective Pyrimidine-Based Aldosterone Synthase (CYP11B2) Inhibitors
Sparks, Steven M.
Danger, Dana P.
Hoekstra, William J.
Leesnitzer, Tony
Schotzinger, Robert J.
Yates, Christopher M.
Becherer, J. David
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (07): : 1056 - 1060
[4] Discovery of Novel Pyrazole-Based Selective Aldosterone Synthase (CYP11B2) Inhibitors: A New Template to Coordinate the Heme-Iron Motif of CYP11B2
Sakakibara, Ryo
Sasaki, Wataru
Onda, Yuichi
Yamaguchi, Minami
Ushirogochi, Hideki
Hiraga, Yuki
Sato, Kanako
Nishio, Masashi
Egi, Yasuhiro
Takedomi, Kei
Shimizu, Hidetoshi
Ohbora, Tomoko
Akahoshi, Fumihiko
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (13) : 5594 - 5608
[5] Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity
Meyers, Kenneth
Cogan, Derek A.
Burke, Jennifer
Arenas, Raquel
Balestra, Michael
Brown, Nicholas F.
Chen, Zhidong
Cerny, Matthew A.
Clifford, Holly E.
Colombo, Federico
Fader, Lee
Frederick, Kosea S.
Guo, Xin
Goldberg, Daniel
Hornberger, Keith R.
Kugler, Stanley
Lord, John
Marshall, Daniel R.
Moss, Neil
Parmentier, Jean-Huges
Richman, Jeremy R.
Schmenk, Jennifer
Weldon, Steven M.
Yu, Maolin
Zhang, Michael
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (05) : 979 - 984
[6] Development and evaluation of a pharmacophore model for inhibitors of aldosterone synthase (CYP11B2)
Ulmschneider, S
Negri, M
Voets, M
Hartmann, RW
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (01) : 25 - 30
[7] Identification of a Novel CYP11B2 Variant in a Family with Varying Degrees of Aldosterone Synthase Deficiency
Garrelfs, Mark R.
Rinne, Tuula
Hillebrand, Jacquelien J.
Lauffer, Peter
Bijlsma, Merijn W.
Grinten, Hedi L. Claahsen-van der
de Leeuw, Nicole
Finken, Martijn J. J.
Rotteveel, Joost
Zwaveling-Soonawala, Nitash
Nieuwdorp, Max
van Trotsenburg, Paul
Mooij, Christiaan F.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2024, 16 (01) : 95 - 101
[8] Identification of a novel CYP11B2 variant in a family with varying degrees of aldosterone synthase deficiency
Garrelfs, Mark
Rinne, Tuula
Hillebrand, Jacquelien
Lauffer, Peter
Bijlsma, Merijn
Claahsen-van der Grinten, Hedi
de Leeuw, Nicole
Finken, Martijn
Rotteveel, Joost
Zwaveling-Soonawala, Nitash
Nieuwdorp, Max
van Trotsenburg, Paul
Mooij, Christiaan
HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 116 - 116
[9] The Innovation of a Novel Drug Screening System for the Inhibitors of Aldosterone Synthase Gene (CYP11B2) Expression
Ito, Ryo
Matsuda, Ken
Uruno, Akira
Yokoyama, Atsushi
Sugawara, Akira
ENDOCRINE REVIEWS, 2014, 35 (03)
[10] Novel mutations in the CYP11B2 gene causing aldosterone synthase deficiency
Li, Niu
Li, Juan
Ding, Yu
Yu, Tingting
Shen, Yongnian
Fu, Qihua
Shen, Yiping
Huang, Xiaodong
Wang, Jian
MOLECULAR MEDICINE REPORTS, 2016, 13 (04) : 3127 - 3132

← 1 2 3 4 5 →